Diagnostic News and Research

RSS

No clear consensus on prevalence, diagnosis, management, and prevention of food allergies

A review of previous research indicates that there are few high-quality studies on food allergies, with limited uniform criteria for making a diagnosis and determining prevalence and effective treatments, according to an article in the May 12 issue of JAMA.

13 May 2010

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

St. Jude Medical, Inc., a global medical device company, today announced it will display a number of new products and clinical solutions from the company's Cardiac Rhythm Management and Atrial Fibrillation Divisions at Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.

13 May 2010

U.S. expands HIV/AIDS programs in Caribbean

Representatives from the U.S. and Caribbean Community (CARICOM) on Tuesday signed an agreement to expand PEPFAR programs to 12 other Caribbean nations during a gathering in Georgetown, Guyana, Agence France-Presse reports (5/11).

13 May 2010

Report describes imaging features of superior mesenteric artery aneurysm

A recent case report published on May 14, 2010 in World Journal of Gastroenterology describes the imaging features of a ruptured superior mesenteric artery aneurysm,which created a giant hematoma and mimicked a pancreatic mass, with mild dilatation of main pancreatic duct.

13 May 2010

New case report addresses diagnostic significance of CT and MRI for DCF

Duodenocaval fistula is an uncommon but lethal clinical entity. The high mortality has been attributed to the difficulty of diagnosis before attempts at definitive therapy.

13 May 2010

New approach to harness and modulate enzyme activity

An Arizona State University graduate student, Jinglin Fu, in collaboration with Biodesign Institute researchers Neal Woodbury and Stephen Albert Johnston, has pioneered a technique that improves on scientists' ability to harness and modulate enzyme activity.

12 May 2010

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.

12 May 2010

OriGene Technologies, ISB to create proteotypic PeptideAtlas and SRM/MRM mass spectrometry standard database

OriGene Technologies, Inc., a leading gene-centric life sciences company, and the Institute for Systems Biology (ISB), announce plans to create a proteotypic PeptideAtlas and develop an SRM/MRM (single reaction monitoring, multiple reaction monitoring) mass spectrometry standard database for 5,000 human proteins. The new collaboration will apply ISB's novel systems biology mass spectrometry expertise to OriGene's large collection of full length human proteins.

12 May 2010

Stereotaxis launches Vdrive module for remote manipulation of diagnostic devices during EP procedures

Stereotaxis, Inc. today announces the introduction of its new Vdrive™, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during electrophysiology (EP) procedures. The company is planning to preview the Vdrive at the HRS meeting this week, and will be commercially available when regulatory processes are complete.

12 May 2010

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.

12 May 2010

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics.

12 May 2010

Prenatal screening, genetic counseling essential for preventing alpha-thalassemia: Researchers

Researchers from Mahidol University have developed a rapid, high-throughput screening method for prevention and control of thalassemia. The related report by Munkongdee et al, "Rapid diagnosis of α-thalassemia by melting curve analysis," appears in the May 2010 issue of The Journal of Molecular Diagnostics.

12 May 2010

Compugen discovers CGEN-928 as antibody drug target for treatment of multiple myeloma

Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.

12 May 2010

Study reveals association between cardiac vagal activity and functional somatic symptoms

A study in the current issue of Psychotherapy and Psychosomatics outlines some novel insights between cardiac vagal activity [heart rate variability in the high-frequency band (HRV-HF)] and symptoms that do not find an organic explanation.

11 May 2010

Rosetta Genomics announces USPTO notice of allowance for Sanger hsa-miR-451

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).

11 May 2010

New disposable measuring device monitors body's vital functions

Physiological signals can nowadays be easily monitored with measurement devices implanted inside a living body. The object - animal or human - is barely aware of the presence of the implant.

11 May 2010

LifeWatch Services to unveil advanced AF TeleClinic service at HRS Annual Meeting

LifeWatch Services, Inc., a subsidiary of LifeWatch AG, will unveil its advanced AF TeleClinic service offering this week at the Heart Rhythm Society (HRS) Annual Meeting taking place in Denver, Colorado. The AF TeleClinic service, empowered with the latest communication, IT and medical technologies, ensures physicians are well equipped to deliver optimal diagnostic and treatment options to their patients.

11 May 2010

Challenges faced in cardiac imaging

When patients present with chest pain or other high-risk symptoms of heart problems, doctors increasingly rely on nuclear imaging and computed tomography (CT) tests to find out whether there is evidence of heart disease, blockages in the coronary arteries or reduced blood flow to the heart. Results of these procedures can help guide life-saving prevention and treatment options.

11 May 2010

Study finds familial restless legs syndrome more prominent among French Canadian women

Restless legs syndrome, which causes an irresistible desire to move legs, appears to be a hereditary condition that's more prominent among French Canadian women and may be caused by a combination of genetic influences and environmental effects. According to a large-scale study published in the Archives of Neurology, siblings of people affected by restless legs syndrome are three and a half times more likely to develop the disease.

11 May 2010

BIOTRONIK launches TactiCath irrigated RF contact force ablation catheter for treating AF

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of remote monitoring technologies today announced the market release of the TactiCath catheter. The TactiCath catheter, an Endosense company product, is an irrigated RF contact force ablation catheter with features that offer a major advance in ablation therapy for patients with cardiac arrhythmias and particularly Atrial Fibrillation (AF).

11 May 2010

Diagnostic News and Research

No clear consensus on prevalence, diagnosis, management, and prevention of food allergies

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

U.S. expands HIV/AIDS programs in Caribbean

Report describes imaging features of superior mesenteric artery aneurysm

New case report addresses diagnostic significance of CT and MRI for DCF

New approach to harness and modulate enzyme activity

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

OriGene Technologies, ISB to create proteotypic PeptideAtlas and SRM/MRM mass spectrometry standard database

Stereotaxis launches Vdrive module for remote manipulation of diagnostic devices during EP procedures

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

Prenatal screening, genetic counseling essential for preventing alpha-thalassemia: Researchers

Compugen discovers CGEN-928 as antibody drug target for treatment of multiple myeloma

Study reveals association between cardiac vagal activity and functional somatic symptoms

Rosetta Genomics announces USPTO notice of allowance for Sanger hsa-miR-451

New disposable measuring device monitors body's vital functions

LifeWatch Services to unveil advanced AF TeleClinic service at HRS Annual Meeting

Challenges faced in cardiac imaging

Study finds familial restless legs syndrome more prominent among French Canadian women

BIOTRONIK launches TactiCath irrigated RF contact force ablation catheter for treating AF

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News